Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 566,287 | 623,628 | +57,341 | $25.50M | $36.90M | 9.11% | +$11.40M |
| Nuvalent Inc | 157,750 | 465,710 | +307,960 | $11.85M | $35.33M | 8.72% | +$23.48M |
| Avidity Biosciences Inc | 489,303 | 517,734 | +28,431 | $12.49M | $21.15M | 5.22% | +$8.66M |
| UroGen Pharma Ltd.(URGN) | 508,587 | 1,102,000 | +593,413 | $7.63M | $18.49M | 4.57% | +$10.86M |
| Erasca, Inc.(ERAS) | 223,845 | 7,816,926 | +7,593,081 | $461.1K | $18.45M | 4.55% | +$17.99M |
| Morphic Hldg Inc | 483,972 | 486,306 | +2,334 | $17.04M | $16.57M | 4.09% | -$467.4K |
| Akero Therapeutics Inc | 399,949 | 625,087 | +225,138 | $10.10M | $14.66M | 3.62% | +$4.56M |
| Celldex Therapeutics, Inc.(CLDX) | 299,316 | 374,910 | +75,594 | $12.56M | $13.88M | 3.43% | +$1.31M |
| Intra-Cellular Therapies Inc | 34,807 | 192,345 | +157,538 | $2.41M | $13.17M | 3.25% | +$10.77M |
| Poseida Therapeutics Inc | 3,596,476 | 3,607,999 | +11,523 | $11.47M | $10.54M | 2.60% | -$937.4K |
| Cogent Biosciences, Inc.(COGT) | 1,036,667 | 1,206,214 | +169,547 | $6.97M | $10.17M | 2.51% | +$3.20M |
| Insmed Incorporated(INSM) | 113,616 | 140,000 | +26,384 | $3.08M | $9.38M | 2.32% | +$6.30M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 0 | 36,000 | +36,000 | $0 | $8.75M | 2.16% | +$8.75M |
| Elutia Inc.CL A(ELUT) | 78,580 | 1,603,580 | +1,525,000 | $247.5K | $7.95M | 1.96% | +$7.71M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 31,980 | 172,492 | +140,512 | $1.25M | $7.81M | 1.93% | +$6.55M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,113,007 | 1,075,812 | -37,195 | $15.30M | $7.61M | 1.88% | -$7.70M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 370,000 | +370,000 | $0 | $7.60M | 1.88% | +$7.60M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 183,776 | 184,662 | +886 | $7.96M | $7.58M | 1.87% | -$380.8K |
| C4 Therapeutics, Inc.(CCCC) | 1,435,931 | 1,442,841 | +6,910 | $11.73M | $6.67M | 1.65% | -$5.07M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 42,000 | +42,000 | $0 | $6.64M | 1.64% | +$6.64M |
| Kalvista Pharmaceuticals Inc | 561,183 | 560,883 | -300 | $6.66M | $6.61M | 1.63% | -$48.4K |
| Veracyte, Inc.(VCYT) | 280,773 | 282,248 | +1,475 | $6.22M | $6.12M | 1.51% | -$105.6K |
| ABIVAX Société AnonymeADS(ABVX) | 75,000 | 455,800 | +380,800 | $1.07M | $6.03M | 1.49% | +$4.95M |
| Olema Pharmaceuticals, Inc.(OLMA) | 515,317 | 546,863 | +31,546 | $5.83M | $5.92M | 1.46% | +$83.7K |
| ADC Therapeutics SASHS(ADCT) | 501,222 | 1,768,770 | +1,267,548 | $2.25M | $5.59M | 1.38% | +$3.34M |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.20M | $5.11M | 1.26% | -$90.0K |
| Mersana Therapeutics Inc | 2,968,798 | 2,500,585 | -468,213 | $13.30M | $5.03M | 1.24% | -$8.27M |
| Gossamer Bio, Inc.(GOSS) | 6,130,268 | 5,500,000 | -630,268 | $7.23M | $4.95M | 1.22% | -$2.28M |
| TELA Bio, Inc.(TELA) | 776,851 | 1,000,000 | +223,149 | $4.40M | $4.70M | 1.16% | +$295.3K |
| Disc Medicine, Inc.(IRON) | 0 | 101,187 | +101,187 | $0 | $4.56M | 1.13% | +$4.56M |
| Biogen Inc.(BIIB) | 19,365 | 19,365 | 0 | $4.18M | $4.49M | 1.11% | +$313.5K |
| Verona Pharma PlcADS | 136,714 | 304,633 | +167,919 | $2.20M | $4.40M | 1.09% | +$2.21M |
| Geron Corporation(GERN) | 250,000 | 999,270 | +749,270 | $825.0K | $4.24M | 1.05% | +$3.41M |
| Biohaven Ltd.(BHVN) | 0 | 100,000 | +100,000 | $0 | $3.47M | 0.86% | +$3.47M |
| Longboard Pharmaceuticals In | 0 | 122,849 | +122,849 | $0 | $3.32M | 0.82% | +$3.32M |
| Praxis Precision Medicines, Inc.(PRAX) | 190,556 | 67,296 | -123,260 | $11.63M | $2.78M | 0.69% | -$8.84M |
| Structure Therapeutics IncADS | 10,000 | 70,516 | +60,516 | $428.6K | $2.77M | 0.68% | +$2.34M |
| Biodesix, Inc.(BDSX) | 0 | 1,808,959 | +1,808,959 | $0 | $2.77M | 0.68% | +$2.77M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 79,194 | 79,194 | 0 | $1.99M | $2.71M | 0.67% | +$718.3K |
| Solid Biosciences Inc | 1,325,065 | 472,995 | -852,070 | $17.65M | $2.68M | 0.66% | -$14.97M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 260,009 | +260,009 | $0 | $2.59M | 0.64% | +$2.59M |
| Cerus Corporation(CERS) | 1,465,744 | 1,465,744 | 0 | $2.77M | $2.58M | 0.64% | -$190.5K |
| Compugen Ltd.(CGEN) | 1,000,000 | 1,501,113 | +501,113 | $2.58M | $2.52M | 0.62% | -$58.1K |
| Trevi Therapeutics, Inc.(TRVI) | 844,235 | 844,235 | 0 | $2.91M | $2.52M | 0.62% | -$396.8K |
| Kodiak Sciences Inc.(KOD) | 1,238,822 | 1,062,062 | -176,760 | $6.52M | $2.50M | 0.62% | -$4.02M |
| Jasper Therapeutics, Inc.(JSPR) | 109,892 | 109,892 | 0 | $3.23M | $2.49M | 0.62% | -$731.9K |
| Engene Holdings Inc COM | 0 | 263,841 | +263,841 | $0 | $2.49M | 0.61% | +$2.49M |
| Wave Life Sciences, Inc.SHS(WVE) | 495,471 | 495,471 | 0 | $3.06M | $2.47M | 0.61% | -$584.7K |
| Fulcrum Therapeutics, Inc.(FULC) | 398,436 | 398,436 | 0 | $3.76M | $2.47M | 0.61% | -$1.29M |
| Evogene LtdSHS | 3,085,503 | 3,079,739 | -5,764 | $2.31M | $2.00M | 0.49% | -$311.1K |
| Stoke Therapeutics, Inc.(STOK) | 0 | 141,518 | +141,518 | $0 | $1.91M | 0.47% | +$1.91M |
| MacroGenics, Inc.(MGNX) | 478,079 | 370,000 | -108,079 | $7.04M | $1.57M | 0.39% | -$5.46M |
| Modular Med Inc | 900,000 | 900,000 | 0 | $1.67M | $1.42M | 0.35% | -$243.0K |
| Zura Bio LimitedCL A(ZURA) | 328,504 | 328,504 | 0 | $844.3K | $1.15M | 0.28% | +$305.5K |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 40,000 | +40,000 | $0 | $1.09M | 0.27% | +$1.09M |
| Yarrow Bioscience Inc(YARW) | 86,383 | 467,397 | +381,014 | $265.2K | $920.8K | 0.23% | +$655.6K |
| EyePoint, Inc.(EYPT) | 247,968 | 100,000 | -147,968 | $5.13M | $870.0K | 0.21% | -$4.26M |
| 89bio Inc | 92,298 | 92,298 | 0 | $1.07M | $739.3K | 0.18% | -$335.0K |
| Molecular Templates Inc | 354,608 | 623,838 | +269,230 | $794.3K | $717.4K | 0.18% | -$76.9K |
| Fractyl Health, Inc.(GUTS) | 166,666 | 166,666 | 0 | $1.23M | $711.7K | 0.18% | -$521.7K |
| Soleno Therapeutics Inc | 0 | 15,000 | +15,000 | $0 | $612.0K | 0.15% | +$612.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 558,466 | 558,466 | 0 | $843.3K | $484.5K | 0.12% | -$358.8K |
| Relmada Therapeutics, Inc.(RLMD) | 99,379 | 99,379 | 0 | $462.1K | $298.1K | 0.07% | -$164.0K |
| Aligos Therapeutics Inc | 655,515 | 655,515 | 0 | $642.4K | $229.4K | 0.06% | -$413.0K |
| Vaxcyte, Inc.(PCVX) | 0 | 2,500 | +2,500 | $0 | $188.8K | 0.05% | +$188.8K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 104,828 | 104,828 | 0 | $31.4K | $6.4K | 0.00% | -$25.0K |
| Adicet Bio Inc | 331,279 | 0 | -331,279 | $778.5K | $0 | — | -$778.5K |
| Alpine Immune Sciences Inc | 199,020 | 0 | -199,020 | $7.89M | $0 | — | -$7.89M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 500,000 | 0 | -500,000 | $1.42M | $0 | — | -$1.42M |
| Apogee Therapeutics Inc | 50,000 | 0 | -50,000 | $3.32M | $0 | — | -$3.32M |
| Boundless Bio, Inc.(BOLD) | 312,500 | 0 | -312,500 | $4.45M | $0 | — | -$4.45M |
| Crinetics Pharmaceuticals In | 127,835 | 0 | -127,835 | $5.98M | $0 | — | -$5.98M |
| Cytokinetics, Incorporated(CYTK) | 50,000 | 0 | -50,000 | $3.51M | $0 | — | -$3.51M |
| DexCom, Inc.(DXCM) | 20,000 | 0 | -20,000 | $2.77M | $0 | — | -$2.77M |
| Immunome, Inc.(IMNM) | 7,489 | 0 | -7,489 | $184.8K | $0 | — | -$184.8K |
| Krystal Biotech, Inc.(KRYS) | 10,000 | 0 | -10,000 | $1.78M | $0 | — | -$1.78M |
| Mineralys Therapeutics, Inc.(MLYS) | 56,944 | 0 | -56,944 | $735.1K | $0 | — | -$735.1K |
| Newamsterdam Pharma Company ORDINARY SHARES | 99,612 | 0 | -99,612 | $2.36M | $0 | — | -$2.36M |
| Perspective Therapeutics, Inc.(CATX) | 8,108,108 | 0 | -8,108,108 | $9.65M | $0 | — | -$9.65M |
| Pliant Therapeutics, Inc.(PLRX) | 183,392 | 0 | -183,392 | $2.73M | $0 | — | -$2.73M |
| Rezolute, Inc.(RZLT) | 151,985 | 0 | -151,985 | $387.6K | $0 | — | -$387.6K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 101,002 | 0 | -101,002 | $2.72M | $0 | — | -$2.72M |
| Scholar Rock Holding Corporation(SRRK) | 199,415 | 0 | -199,415 | $3.54M | $0 | — | -$3.54M |
| Terns Pharmaceuticals Inc | 250,551 | 0 | -250,551 | $1.64M | $0 | — | -$1.64M |
| Viking Therapeutics, Inc.(VKTX) | 20,000 | 0 | -20,000 | $1.64M | $0 | — | -$1.64M |
| Xenon Pharmaceuticals Inc.(XENE) | 66,090 | 0 | -66,090 | $2.85M | $0 | — | -$2.85M |